Share on LinkedInShare on LinkedIn

ARTICLE · 19 NOVEMBER 2021

IP Waiver And Covid-19 Vaccines

Khurana & Khurana, Advocates and IP Attorneys
Explore more from Khurana & Khurana, Advocates and IP Attorneys

Since 2019, coronavirus hit the whole world and it is now for 2 years, we are facing this unfortunate pandemic.

IndiaIntellectual Property

Since 2019, coronavirus hit the whole world and it is now for 2 years, we are facing this unfortunate pandemic. As of 27 October 2021, there is a total of 24.43cr cases and 49.61lakh deaths worldwide with the USA on top followed by India and Brazil. The figures are alarming but the ground situation is way more harrowing. This pandemic has caused great distress to almost everyone in some way or other. During this pandemic, we have come across many things such as vaccines, IPR, NDMA, etc. from which we aren't completely familiar before the pandemic. One of the issues which we are going to discuss further in this article is the relation and issue pertaining to IPR in the covid vaccine.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from